The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.

@article{Eichinger1997TheRO,
  title={The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.},
  author={Sabine Eichinger and Ingrid Pabinger and Andreas Stuempflen and Mirko Hirschl and Christine Bialonczyk and Barbara Taback Schneider and Christine Mannhalter and E. Minar and Klaus Lechner and Paul Alexander Kyrle},
  journal={Thrombosis and haemostasis},
  year={1997},
  volume={77 4},
  pages={624-8}
}
Thromboprophylaxis with oral anticoagulants up to six months is established in patients after a first venous thromboembolic event (VTE). The risk of recurrent VTE is still considerable thereafter, and it is uncertain whether some patients might benefit from extended anti-coagulation. We performed a prospective, multicenter trial (4 thrombosis centers) and evaluated in 380 patients with a first or recurrent VTE (patients with a deficiency of antithrombin, protein C, protein S or plasminogen… CONTINUE READING